Joel D Buckley

US Patent:

D687632, Aug 13, 2013

Filed:

Feb 11, 2011

Appl. No.:

29/385305

Inventors:

Randal High - Bloomington MN, US
Joel Buckley - Plymouth MN, US

Assignee:

Drenaline Products, LLC - Plymouth MN

International Classification:

0301

US Classification:

D 3255

US Patent:

D694662, Dec 3, 2013

Filed:

Nov 9, 2011

Appl. No.:

29/406066

Inventors:

Joel Buckley - Plymouth MN, US

International Classification:

1101

US Classification:

D11 3

US Patent:

20110290683, Dec 1, 2011

Filed:

May 26, 2011

Appl. No.:

13/117024

Inventors:

Randal High - Bloomington MN, US
Joel Buckley - Plymouth MN, US

International Classification:

A63B 55/06
G09F 17/00

US Classification:

2063157, 116173

Abstract:

A golf bag banner includes a flexible body movable between at least a first position and a second position and a connector mechanism to secure the flexible body to a movable leg of a golf bag. A fixture is provided to hold the banner along the length of leg. A golf bag is essentially a container to receive golf clubs therein. A stand mechanism can be connected to the container to provide a bag stand position and a retracted position. The bag banner can be fixed to the stand mechanism, e.g., connected between two legs of the stand mechanism. The bag banner can include a flexible body, e.g., a fabric, movable between at least the stand position and the retracted position and a connector system to secure the flexible body to the two legs. The bag banner can incorporate logos and other insignia that a manufacturer or golfer would like to display with his/her golf bag.

US Patent:

20130020367, Jan 24, 2013

Filed:

Jul 20, 2012

Appl. No.:

13/554529

Inventors:

Joel BUCKLEY - Plymouth MN, US

International Classification:

A63B 57/00
A44C 5/00
A45F 5/00

US Classification:

224584, 224219, 224183

Abstract:

A display device for a golf ball marker includes a mechanism for temporary attaching the display device or insert at a visible position on a person, and a holding portion (structure) attached to the mechanism. The ball marker holding portion also includes a magnetic force portion, and a gripping portion adapted to apply a holding force on a ball marker. The magnetic force portion includes a magnet; and an element including a recess for receiving the magnet. A wristband can operate as the display device for the ball marker, which is removable from the temporary attachment to the wristband. The attachment can hold the marker in place while the person moves and plays golf, e.g., swings a golf club. The wristband can be a silicone wristband.

US Patent:

20130209545, Aug 15, 2013

Filed:

Jan 22, 2013

Appl. No.:

13/747151

Inventors:

Hybrid Medical, LLC - , US
Joel BUCKLEY - Plymouth MN, US
Harold HOIUM - Eden Prairie MN, US

Assignee:

HYBRID MEDICAL, LLC - Plymouth MN

International Classification:

A61K 38/44
A61K 31/4418

US Classification:

424450, 424 944, 424 943

Abstract:

The invention provides topical compositions and methods for using the compositions. The compositions can be used for the treatment of fibrotic or connective tissue disorders involving scarring, sub-dermal plaque accumulations, or fibrosis of muscle tissue. The disorders can be painlessly treated by the topical application of a composition described herein. One or more calcium channel blocker agents can serve as an active ingredient of the compositions, optionally in combination with, for example, one or more of emu oil and superoxide dismutase. The composition can further include pharmaceutically acceptable carriers that can facilitate the non-invasive transdermal delivery of the active(s) to subdermal sites.

US Patent:

20230082254, Mar 16, 2023

Filed:

Aug 19, 2022

Appl. No.:

17/891835

Inventors:

- Eden Prairie MN, US
Joel Buckley - Plymouth MN, US
Harold Hoium - Eden Prairie MN, US

International Classification:

A61K 38/44
A61K 9/00
A61K 31/4422
A61K 38/21
A61K 35/57
A61K 47/24
A61K 31/554
C07D 211/90
A61K 31/40
A61K 9/12
A61K 9/06
A61K 31/277
A61K 45/06

Abstract:

The invention provides topical compositions and methods for using the compositions. The compositions can be used for the treatment of fibrotic or connective tissue disorders involving scarring, sub-dermal plaque accumulations, or fibrosis of muscle tissue. The disorders can be painlessly treated by the topical application of a composition described herein. One or more calcium channel blocker agents can serve as an active ingredient of the compositions, optionally in combination with, for example, one or more of emu oil and superoxide dismutase. The composition can further include pharmaceutically acceptable carriers that can facilitate the non-invasive transdermal delivery of the active(s) to subdermal sites.

US Patent:

20200121764, Apr 23, 2020

Filed:

Oct 28, 2019

Appl. No.:

16/666027

Inventors:

- Eden Prairie MN, US
Joel Buckley - Plymouth MN, US
Harold Hoium - Eden Prairie MN, US

International Classification:

A61K 38/44
A61K 45/06
A61K 31/277
A61K 9/06
A61K 9/12
A61K 31/40
C07D 211/90
A61K 31/554
A61K 47/24
A61K 35/57
A61K 38/21
A61K 31/4422
A61K 9/00

Abstract:

The invention provides topical compositions and methods for using the compositions. The compositions can be used for the treatment of fibrotic or connective tissue disorders involving scarring, sub-dermal plaque accumulations, or fibrosis of muscle tissue. The disorders can be painlessly treated by the topical application of a composition described herein. One or more calcium channel blocker agents can serve as an active ingredient of the compositions, optionally in combination with, for example, one or more of emu oil and superoxide dismutase. The composition can further include pharmaceutically acceptable carriers that can facilitate the non-invasive transdermal delivery of the active(s) to subdermal sites.

US Patent:

20160129091, May 12, 2016

Filed:

Dec 28, 2015

Appl. No.:

14/981167

Inventors:

- Eden Prairie MN, US
Joel Buckley - Plymouth MN, US
Harold Hoium - Eden Prairie MN, US

International Classification:

A61K 38/44
A61K 35/57
A61K 38/21
A61K 9/00
A61K 31/4422

Abstract:

The invention provides topical compositions and methods for using the compositions. The compositions can be used for the treatment of fibrotic or connective tissue disorders involving scarring, sub-dermal plaque accumulations, or fibrosis of muscle tissue. The disorders can be painlessly treated by the topical application of a composition described herein. One or more calcium channel blocker agents can serve as an active ingredient of the compositions, optionally in combination with, for example, one or more of emu oil and superoxide dismutase. The composition can further include pharmaceutically acceptable carriers that can facilitate the non-invasive transdermal delivery of the active(s) to subdermal sites.